Physician profile
Todd C Rumsey
NPI 1336139062
$3,679.53
in general payments reported to CMS, 2019-2025
19 companies · $361 in 2025
The $361 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $84.30 · 2020: $1,258 · 2022: $138 · 2023: $1,620 · 2024: $218 · 2025: $361.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,500 · Food and Beverage: $698.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,500.00 |
| Food and Beverage | $698.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Channel Medsystems, INC. | $1,565.54 | 2023-2025 | |
| Therapeuticsmd, INC. | $1,213.96 | 2019-2020 | |
| Hologic Sales and Service, LLC | $115.19 | 2020-2025 | Novasure, Myosure Tissue Removal Device, Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Organon LLC | $110.14 | 2023-2025 | Nexplanon |
| Sumitomo Pharma America, INC. | $105.01 | 2024-2025 | Myfembree |
| Amgen INC. | $91.00 | 2019-2025 | Evenity, Prolia |
| Pfizer INC. | $87.26 | 2022-2024 | |
| Smith+Nephew, INC. | $66.44 | 2022 | |
| Abbvie INC. | $64.50 | 2019-2025 | |
| Astellas Pharma US INC | $59.11 | 2025 | Veozah |
| Exeltis, USA INC. | $44.22 | 2023-2025 | Slynd |
| Mayne Pharma Commercial LLC | $33.70 | 2023-2024 | |
| Shield Therapeutics INC | $30.71 | 2023-2024 | Accrufer |
| Millicent US INC | $19.27 | 2025 | Intrarosa |
| Biogen, INC. | $18.83 | 2025 | Zurzuvae |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $15.53 | 2025 | Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $13.67 | 2023 | |
| Merck Sharp & Dohme LLC | $13.34 | 2019 | |
| Coopersurgical, INC. | $12.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Rumsey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.